Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Wagner

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Molecular Microbiology|July 28, 2010
H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuOEdze R Westra, Umit Pul, Nadja Heidrich, et al.
Journal of Cardiovascular Pharmacology|April 18, 2007
Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppressionYung-Wu Chen, Morey L Smith, Michael Sheets, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2016
Discovery of fluorobenzimidazole HCV NS5A inhibitorsJohn T Randolph, Charles A Flentge, Pamela Donner, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimizationWilliam J Sanders, Vicki L Nienaber, Claude G Lerner, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2005
Rapamycin analogs with reduced systemic exposureRolf Wagner, Karl W Mollison, Luping Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motifA Chris Krueger, John T Randolph, David A DeGoey, et al.
Nature Structural & Molecular Biology|April 5, 2011
Structural basis for CRISPR RNA-guided DNA recognition by CascadeMatthijs M Jore, Magnus Lundgren, Esther van Duijn, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Molecular Microbiology|July 28, 2010
H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuOEdze R Westra, Umit Pul, Nadja Heidrich, et al.
Journal of Cardiovascular Pharmacology|April 18, 2007
Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppressionYung-Wu Chen, Morey L Smith, Michael Sheets, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2016
Discovery of fluorobenzimidazole HCV NS5A inhibitorsJohn T Randolph, Charles A Flentge, Pamela Donner, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimizationWilliam J Sanders, Vicki L Nienaber, Claude G Lerner, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2005
Rapamycin analogs with reduced systemic exposureRolf Wagner, Karl W Mollison, Luping Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motifA Chris Krueger, John T Randolph, David A DeGoey, et al.
Nature Structural & Molecular Biology|April 5, 2011
Structural basis for CRISPR RNA-guided DNA recognition by CascadeMatthijs M Jore, Magnus Lundgren, Esther van Duijn, et al.
Pageof 6